Japan's auto industry continues to be affected by the earthquake, and the auto parts giant Dawning Brake Industry revealed that quality inspection data falsified, like another shock.The company recently announced that more than 110,000 of its product quality inspection data were falsified or falsified.
Japanese auto parts giant Dawn Brake Industry said on Tuesday that more than 114000 quality inspection data of brake and parts produced by the company's factories in Japan were falsified or fabricated.Of these, about 5,000 failed to meet the standards agreed with car manufacturers.Dawning Brakes also said the fraud dates back to at least 2001 and spans about 20 years.
According to Japanese media reports, the fraud incident affected many Japanese car companies, including Toyota and Nissan.
Toyota is the company's largest shareholder with a stake of more than 11%, according to information posted on the company's website.
Yesterday the reporter contacted the dawning brake headquarters in Japan, the person in charge of the response said that the involved parts affected 10 Japanese car companies, but the specific name of the enterprise can not be made public.
However, he also said that the car companies after the re-inspection of the product performance is not a problem, so Dawning brake and the related car companies are not currently planning a recall.
As for whether the Chinese market is involved, the official said that it could not be confirmed whether the parts involved were exported to overseas markets after being assembled into cars.
Dawn Brake explained that the main reason for the data fraud problem is the company's internal supervision mechanism is not sound, weak awareness of compliance.
The company said it has submitted an investigation report to Japan's Ministry of Land, Infrastructure, Transport and other authorities, and has punished top executives, including its president, with pay cuts.
It also said that information technology will be introduced into the quality inspection link in the future to reduce the proportion of manual quality inspection.
No injuries have been reported, but it is the second recent fraud scandal in Japan's manufacturing sector to cause shock.
The move comes after Kobayashi Chemical, a Japanese pharmaceutical company, was ordered to suspend operations for 116 days after more than 200 patients were found to have suffered health damage due to counterfeiting.
A spate of bad news has also cast another shadow over Japan's manufacturing halo.